Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, La Roche sur Yon, France.
1] Pôle des Maladies de l'Appareil Digestif, Service de Gastroentérologie-Pancréatologie, Hôpital Beaujon, AP-HP, Clichy, France [2] Inserm U773-CRB3, Université Paris-Diderot, Clichy, France.
J Perinatol. 2014 Feb;34(2):87-94. doi: 10.1038/jp.2013.161. Epub 2013 Dec 19.
This article aims to draw together recent thinking on pregnancy and acute pancreatitis (AP), with a particular emphasis on pregnancy complications, birth outcomes and management of AP during pregnancy contingent on the etiology. AP during pregnancy is a rare but severe disease with a high maternal-fetal mortality, which has recently decreased thanks to earlier diagnosis and some maternal and neonatal intensive care improvement. AP usually occurs during the third trimester or the early postpartum period. The most common causes of AP are gallstones (65 to 100%), alcohol abuse and hypertriglyceridemia. Although the diagnostic criteria for AP are not specific for pregnant patients, Ranson and Balthazar criteria are used to evaluate the severity and treat AP during pregnancy. The fetal risks from AP during pregnancy are threatened preterm labor, prematurity and in utero fetal death. In cases of acute biliary pancreatitis during pregnancy, a consensual strategy could be adopted according to the gestational age, and taking in consideration the high risk of recurrence of AP (70%) with conservative treatment and the specific risks of each treatment. This could include: conservative treatment in first trimester and laparoscopic cholecystectomy in second trimester. During the third trimester, conservative treatment or endoscopic retrograde cholangiopancreatography with biliary endoscopic sphincterotomy, and laparoscopic cholecystectomy in early postpartum period are recommended. A multidisciplinary approach, including gastroenterologists and obstetricians, seems to be the key in making the best choice for the management of AP during pregnancy.
本文旨在综合近期关于妊娠合并急性胰腺炎(AP)的研究进展,重点关注妊娠并发症、母婴结局以及病因相关的妊娠期间 AP 的管理。妊娠合并 AP 虽较为罕见,但病情严重,母胎病死率高。近年来,由于早期诊断和一些母胎重症监护水平的提高,其病死率有所下降。AP 通常发生在妊娠晚期或产后早期。AP 的最常见病因是胆石症(65%~100%)、酗酒和高三酰甘油血症。尽管 AP 的诊断标准不适用于妊娠患者,但仍采用 Ranson 和 Balthazar 标准来评估妊娠期间 AP 的严重程度并进行治疗。妊娠合并 AP 的胎儿风险包括早产、早产和胎儿宫内死亡。对于妊娠合并急性胆源性胰腺炎,可根据孕周采用共识策略,并考虑到保守治疗后 AP 复发率高(70%)以及每种治疗方法的特定风险。具体策略包括:妊娠早期行保守治疗,妊娠中期行腹腔镜胆囊切除术。妊娠晚期则推荐保守治疗或内镜逆行胰胆管造影术联合胆道内镜括约肌切开术,产后早期行腹腔镜胆囊切除术。多学科方法,包括胃肠病学家和妇产科医生,似乎是妊娠合并 AP 管理中做出最佳选择的关键。
J Perinatol. 2013-12-19
Hepatobiliary Pancreat Dis Int. 2016-8
Int J Obstet Anesth. 2012-9-6
Eksp Klin Gastroenterol. 2016
World J Gastroenterol. 2009-12-7
Eur J Obstet Gynecol Reprod Biol. 2011-8-12
Acta Obstet Gynecol Scand. 1995-9
World J Gastroenterol. 2024-8-28
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025-3-20
Int J Emerg Med. 2025-3-3
Case Rep Endocrinol. 2025-1-30
Diagnostics (Basel). 2025-1-23
Am J Case Rep. 2025-2-5
Case Rep Endocrinol. 2024-10-10
J Racial Ethn Health Disparities. 2024-9-9
World J Gastrointest Endosc. 2013-4-16
Surg Laparosc Endosc Percutan Tech. 2012-10
Curr Gastroenterol Rep. 2012-12
Clin Res Hepatol Gastroenterol. 2012-9-7
Int J Obstet Anesth. 2012-9-6
Obstet Gynecol. 2012-8
J Clin Endocrinol Metab. 2012-5-25